Real Consultation Scenario: A Patient with Repeated Implantation Failure
A 42-year-old woman, who had attempted 3 fresh embryo transfers and 2 frozen embryo transfers without implantation, had normal endometrial morphology and thickness, and an embryo grade of 4AA. She consulted in Georgia about "whether ERT endometrial optimization technology is suitable for her." This is a clinically very typical case of "unexplained recurrent implantation failure."
What is Georgia ERT Endometrial Optimization Technology
ERT (Endometrial Receptivity Array) is a technology based on gene expression testing. By collecting endometrial tissue samples and analyzing the expression levels of 236 genes related to endometrial receptivity, it determines whether the endometrium is in the "receptive phase" (suitable for embryo implantation). Several reproductive centers in Georgia have introduced this technology to address recurrent failure caused by a displaced implantation window.
Technical Principle
In a normal menstrual cycle, the endometrium is in the "implantation window" state only during the mid-luteal phase (7-9 days after ovulation). In some women, the implantation window may be advanced, delayed, or shortened in duration. ERT uses gene expression profiling to precisely determine the individualized optimal transfer time, with an error margin typically controlled within ±24 hours.
How Doctors View ERT Technology
The reproductive medicine community generally recognizes the value of ERT for specific populations, but not all patients need it. Clinically, the decision to recommend ERT is primarily based on the number of previous implantation failures and embryo quality. If a woman has transferred at least 2 good-quality embryos without implantation, or has only one embryo and is over 38 years old, doctors tend to recommend ERT testing.
Key Judging Indicators
- Number of implantation failures: ≥2 failed transfers with good-quality embryos
- Embryo quality: At least usable embryos (not grade D)
- Endometrial morphology: Ultrasound and hysteroscopy rule out organic lesions such as polyps, adhesions, and fibroids
- Age: ≥35 years or low ovarian reserve (AMH < 1.0 ng/ml)
Differences Across Age Groups
| Age Group | Probability of Implantation Window Displacement | ERT Recommendation |
|---|---|---|
| ≤30 years | Approximately 10-15% | Generally not recommended unless there is a history of recurrent failure |
| 31-37 years | Approximately 20-25% | Can be considered, especially when only 1-2 embryos are available |
| ≥38 years | Approximately 30-40% | Strongly recommended; age leads to a drift in endometrial gene expression profile |
Actual Process: How Long Does ERT Take in Georgia
Preparation Phase
- Routine embryo culture and biopsy must be completed first (PGT is preferable if performed)
- Confirm at least one frozen embryo available for transfer
Testing Cycle
- In a natural or artificial cycle, simulate menstruation and use hormones to grow the endometrium
- When the endometrial thickness reaches 7mm or more and is type A, on day 5-7 after ovulation or progesterone administration
- Sample is taken via an endometrial biopsy catheter (painless, about 1 minute), and the sample is sent to the genetic laboratory
- Results are usually returned within 2-3 weeks, showing "receptive," "advanced," or "delayed"
- Adjust the transfer time according to the report: for example, if the report shows "delayed by 1 day," postpone the original transfer date by 24 hours
The entire process from starting endometrial preparation to the final transfer takes about 1.5-2 months (including waiting time for results).
Easily Overlooked Details
Timing of Testing Must Be Precise
The sampling time must be at the standard "mid-luteal phase" point, otherwise results may be misinterpreted. Reproductive centers in Georgia usually require sampling on the 6th day after progesterone administration (or the 8th day after the LH surge in a natural cycle).
Embryos Must Be Frozen
Fresh embryo transfer cannot be performed during the ERT testing cycle, as the endometrium may be slightly damaged after the biopsy, and the sampling site needs time to heal. The best option is frozen-thawed embryo transfer. Embryo vitrification technology is very mature, with a thawing survival rate exceeding 95%.
Common Pitfalls
Mistaking ERT for Improving Embryo Quality
ERT only addresses the "time window" issue and cannot compensate for chromosomal abnormalities or poor developmental potential of the embryo. If the embryo itself is abnormal, it will not implant even if the transfer window is perfect.
Ignoring the Impact of Hormone Replacement Cycles
In some patients using artificial cycles, endometrial gene expression may differ from that in natural cycles. Repeated ERT testing may show inconsistent results, so it is recommended to test under a fixed protocol (e.g., HRT cycle).
Suitable and Unsuitable Candidates
Suitable Candidates
- Patients with ≥2 failed transfers of good-quality embryos
- Advanced age (≥38 years) with limited embryo numbers
- Known autoimmune diseases or endometriosis that may affect endometrial receptivity
- History of unexplained recurrent miscarriage
Unsuitable Candidates
- Untreated endometrial pathologies (e.g., intrauterine adhesions, submucosal fibroids)
- No available frozen embryos (ovum pickup cycle must be completed first)
- Financial constraints unable to cover additional testing costs (ERT cost in Georgia is approximately $1000-$1500, excluding cycle fees)
- Patients with a clear pattern of transfer timing and high probability of successful implantation
Frequently Asked Questions
Q: Can ERT testing 100% improve success rates?
A: No. Clinical data show that for patients with a displaced implantation window, the live birth rate can increase by 15%-30% after adjustment with ERT, but failure is still possible. This technology shifts individualized transfer from "empirical judgment" to "genetic verification."
Q: Which centers in Georgia perform ERT?
A: Currently, two large reproductive centers in Tbilisi offer this service. It is necessary to confirm whether the laboratory collaborates with Igenomix or similar entities. It is recommended to directly ask the center if they have locally certified genetic testing qualifications.
Practitioner's Observation (Reproductive Doctor's Perspective)
Having practiced in Georgia for many years, I have observed that the ERT positive rate (i.e., displaced implantation window) is about 20%-25%. The proportion of Chinese patients is high; many choose to come to Georgia due to long waiting times or higher costs in their home country. It is important to note: ERT is not a magic key. The prerequisites for success are an endometrium without organic lesions and a chromosomally normal embryo. For patients with low ovarian reserve who have only formed one embryo, the screening value is greater.
Risk Reminder
ERT is a minimally invasive procedure. Main risks include: slight bleeding after endometrial biopsy (1-2 days), infection probability less than 0.1%, and in very rare cases, result errors due to improper sampling location. Additionally, since testing reagents in Georgia need to be shipped from abroad, a break in the cold chain during sample transport may affect results. It is advisable to choose a center with stable international logistics partnerships.
Before making a final decision, please discuss your personal situation face-to-face with your attending physician. It is not advisable to make a self-judgment based solely on online information.
Comments (0)